Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas-Reference-Cited by-同舟云学术

Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas

Published:2019-03-01 Issue:6 Volume:20 Page:843-854
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Moes-Sosnowska Joanna¹^ORCID,Rzepecka Iwona K.²^ORCID,Chodzynska Joanna³,Dansonka-Mieszkowska Agnieszka²^ORCID,Szafron Lukasz M.¹^ORCID,Balabas Aneta⁴^ORCID,Lotocka Renata²,Sobiczewski Piotr⁵,Kupryjanczyk Jolanta²^ORCID

Affiliation:

1. Department of Immunology, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Poland

2. Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Poland

3. Laboratory of Bioinformatics and Biostatistics, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Poland

4. Department of Genetics, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Poland

5. Department of Gynecologic Oncology, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Poland

Funder

Polish Ministry of Science and Higher Education

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/15384047.2019.1579955

Reference85 articles.

1. Global cancer statistics

2. Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

3. A new standard of care for treatment of ovarian cancer

4. New heteronuclear gold(I)–platinum(II) complexes with cytotoxic properties: Are two metals better than one?

5. Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MORE interpretable multi-omic regulatory networks to characterize phenotypes;2024-01-29

2. Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer;Current Oncology;2023-12-29

3. Next-generation DNA sequencing identifies mutated FANCD2 Gene as a novel Biomarker for monitoring early disease progression and timely therapeutic interventions in advanced phase Chronic Myeloid Leukemia patients;2023-12-19

4. Pancancer Analysis of the Prognostic and immunological Role of FANCD2: A Potential Target for Carcinogenesis and Survival;2023-11-20

5. FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma;European Journal of Medical Research;2023-10-11